Sun Pharmaceutical Industries Limited has informed the Exchange about Newspaper Publication for the special window only for re-lodgement of transfer deeds
SUNPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sun Pharmaceutical Industries has informed the exchanges about a newspaper advertisement published on 19 July 2025 regarding SEBI's special window for re-lodgement of share transfer deeds. The window, which runs from 7 July 2025 to 6 January 2026 (six months), allows investors to re-submit physical share transfer requests that were lodged before the 1 April 2019 deadline and were earlier rejected, returned, or left unprocessed due to documentation deficiencies. All shares re-lodged under this window will be issued only in demat form. The company has published the notice in the Financial Express (all English editions and Ahmedabad Gujarati edition), and has named MUFG Intime India Private Limited (formerly Link Intime India) as its Registrar and Share Transfer Agent for processing such requests.
This is a routine regulatory compliance filing with no direct impact on the company's financials or stock price. Shareholders with old pending physical share transfer requests can use this one-time SEBI window to get their shares transferred, but the broader business and trading outlook for Sun Pharma is unaffected.